Mid-term evolution of Chronic Chagas disease patients hospitalized due to COVID-19

Authors

  • Zaidel EJ Sanatorio Güemes and Univeristy of Buenos Aires, Argentina
  • Segovia EF Sanatorio Güemes
  • Nuñez S Sanatorio Güemes
  • Palomino Romero LC Sanatorio Güemes
  • Caliva E Sanatorio Güemes
  • Arcos Alcívar JF Sanatorio Güemes
  • Perea J Sanatorio Güemes
  • Oliva MA Sanatorio Güemes
  • Gheco L Sanatorio Güemes
  • García Chamorro LG Sanatorio Güemes
  • Elfman M Sanatorio Güemes
  • Cestari HG
  • Villarreal RA Sanatorio Güemes
  • Sosa Liprandi MI Sanatorio Güemes
  • Sosa Liprandi A Sanatorio Güemes and Univeristy of Buenos Aires, Argentina

Keywords:

Chagas Disease, COVID-19, SARS-CoV-2, Pneumonia, Arrhythmias, Heart Failure, Trypanosoma Cruzi

Abstract

This is the first report of mid-term evolution of patients with COVID-19 and Chagas Disease (CD). General characteristics, in-hospital evolution, and mid-term follow up of 12 consecutive patients at a single centre is described. A call for action is needed to screen for CD, especially in endemic areas, as the interaction of both diseases may lead to worse cardiac outcomes.

Downloads

Download data is not yet available.

References

Echeverría LE, Marcus R, Novick G, Sosa-Estani S, Ralston K, Zaidel EJ, et al. WHF IASC Roadmap on Chagas Disease. Global Heart. 2020; 15(1): 26. DOI: https://doi.org/10.5334/gh.484

Alonso-Padilla J, Cortés-Serra N, Pinazo MJ, et al. Strategies to enhance access to diagnosis and treatment for Chagas disease patients in Latin America. Expert Rev Anti Infect Ther. 2019; 17(3): 145-157. doi:10.1080/14787210.2019.1577731

Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506.

Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19) [published online ahead of print, 2020 Jul 27]. JAMA Cardiol. 2020; 10.1001/jamacardio.2020.3557. doi:10.1001/jamacardio.2020.3557

Zaidel EJ, Forsyth CJ, Novick G, Marcus R, Ribeiro ALP, Pinazo M-J, et al.. COVID-19: Implications for People with Chagas Disease. Global Heart. 2020; 15(1): 69. DOI: http://doi.org/10.5334/gh.891

Zaidel EJ, Wyss Quintana FS, Sosa Liprandi Á, et al. Hidroxicloroquina. Mensajes desde la cardiología en tiempos de pandemia por coronavirus [Hydroxychloroquine. Cardiology's viewpoint in times of coronavirus pandemic]. Medicina (B Aires). 2020; 80(3): 271-274.

Roubille C, Richer V, Starnino T, et al. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis. 2015; 74(3): 480-489. doi:10.1136/annrheumdis-2014-206624

Zaroff JG, Cheetham TC, Palmetto N, et al. Association of Azithromycin Use With Cardiovascular Mortality. JAMA Netw Open. 2020; 3(6): e208199. doi:10.1001/jamanetworkopen.2020.8199

Israel Molina, Milena S. Marcolino, Magda C. Pires, et al. Chagas disease and SARS-CoV-2 coinfection does not lead to worse in-hospital outcomes: results from the Brazilian COVID-19 Registry https://www.medrxiv.org/content/10.1101/2021.03.22.21254078v1 doi: https://doi.org/10.1101/2021.03.22.21254078

Li J, Huang DQ, Zou B, et al. Epidemiology of COVID-19: A Systematic Review and Meta-analysis of Clinical Characteristics, Risk factors and Outcomes [published online ahead of print, 2020 Aug 13]. J Med Virol. 2020;10.1002/jmv.26424. doi:10.1002/jmv.26424

Yang, J., et al., Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020; 94: 91-95.doi:10.1016/j.ijid.2020.03.017

Downloads

Published

2021-12-03

How to Cite

1.
Zaidel EJ, Segovia EF, Nuñez S, Palomino Romero LC, Caliva E, Arcos Alcívar JF, Perea J, Oliva MA, Gheco L, García Chamorro LG, Elfman M, Cestari HG, Villarreal RA, Sosa Liprandi MI, Sosa Liprandi Álvaro. Mid-term evolution of Chronic Chagas disease patients hospitalized due to COVID-19. Int Jour HS [Internet]. 2021 Dec. 3 [cited 2022 Jan. 24];(1). Available from: https://ijhsc.com/journal/article/view/38

Issue

Section

Clinical Research

Categories